Oppenheimer & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Buy |
13,420
+10
| +0.1% | +$85 | ﹤0.01% | 1554 |
|
|
2025
Q1 | $108K | Sell |
13,410
-1,000
| -7% | -$8.04K | ﹤0.01% | 1513 |
|
|
2024
Q4 | $129K | Sell |
14,410
-300
| -2% | -$2.69K | ﹤0.01% | 1496 |
|
|
2024
Q3 | $108K | Hold |
14,710
| – | – | ﹤0.01% | 1450 |
|
|
2024
Q2 | $84K | Sell |
14,710
-500
| -3% | -$2.86K | ﹤0.01% | 1389 |
|
|
2024
Q1 | $76.2K | Sell |
15,210
-3,700
| -20% | -$18.5K | ﹤0.01% | 1399 |
|
|
2023
Q4 | $170K | Buy |
18,910
+10
| +0.1% | +$90 | ﹤0.01% | 1302 |
|
|
2023
Q3 | $147K | Hold |
18,900
| – | – | ﹤0.01% | 1296 |
|
|
2023
Q2 | $183K | Sell |
18,900
-2,500
| -12% | -$24.2K | ﹤0.01% | 1299 |
|
|
2023
Q1 | $235K | Buy |
21,400
+3,000
| +16% | +$32.9K | 0.01% | 1205 |
|
|
2022
Q4 | $79.5K | Sell |
18,400
-3,200
| -15% | -$13.8K | ﹤0.01% | 1300 |
|
|
2022
Q3 | $162K | Sell |
21,600
-2,000
| -8% | -$15K | ﹤0.01% | 1251 |
|
|
2022
Q2 | $237K | Buy |
23,600
+1,000
| +4% | +$10K | 0.01% | 1193 |
|
|
2022
Q1 | $280K | Buy |
22,600
+2,600
| +13% | +$32.2K | 0.01% | 1227 |
|
|
2021
Q4 | $457K | Buy |
20,000
+2,200
| +12% | +$50.3K | 0.01% | 1076 |
|
|
2021
Q3 | $394K | Sell |
17,800
-12,764
| -42% | -$283K | 0.01% | 1112 |
|
|
2021
Q2 | $396K | Buy |
30,564
+274
| +0.9% | +$3.55K | 0.01% | 1124 |
|
|
2021
Q1 | $393K | Buy |
+30,290
| New | +$393K | 0.01% | 1068 |
|